Hungary's Richter to maintain operations in Russia, CEO says -website
BUDAPEST, July 1 (Reuters) - Hungarian drug maker Richter
GDRB.BU has experienced pressure from Ukraine to "rethink" its
presence in Russia but the company is not leaving, the company's
chief executive Gabor Orban told website hvg.hu on Friday.
When asked if Russia's warning that it could nationalise
western companies posed a threat to the company, Orban said:
"This cannot be excluded but nothing would justify such a
step as Richter maintains its operations in Russia. The question
rather is how we can ensure continuous operations."
Richter also has operations in Ukraine.
(Reporting by Krisztina Than; Editing by Frank Jack Daniel)
((krisztina.than@thomsonreuters.com;))
Recent news on Richter Gedeon Vegyeszeti Gyar Nyrt
See all newsAI in Hungary could unlock productivity gains of €15 billion, McKinsey says
Brief: Hungary's Richter and Hetero announce cooperation for development of semaglutide injection
Brief: Hungary's Richter and Acrux agree to license transdermal Estradiol spray for Australia
Brief: Hungary's Richter Says 2026 Guidance Fully Reiterated High-Single-Digit Growth In Revenues And Clean EBIT (At Constant Exchange Rates)
Brief: Hungary's Richter says European Commission granted approval for Tuyory, its biosimilar to Tocilizumab